| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.95e-06 | 11 | 226 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.26e-05 | 33 | 226 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 1.62e-04 | 10 | 226 | 3 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 1.62e-04 | 10 | 226 | 3 | GO:0070740 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 4.48e-04 | 32 | 226 | 4 | GO:0099186 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.61e-06 | 100 | 227 | 9 | GO:0043242 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.25e-06 | 89 | 227 | 8 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | MAP1A KATNB1 CRACD BRCA1 SVIL LIMA1 EML4 PPFIA1 CAMSAP3 TRIOBP TRIM37 | 1.06e-05 | 194 | 227 | 11 | GO:0051494 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | MAP1A KATNB1 CRACD BOK BRCA1 SVIL CLEC16A WDR44 LIMA1 EML4 PPFIA1 CAMSAP3 TRIOBP DYNC1LI1 ATM TRIM37 | 1.87e-05 | 421 | 227 | 16 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.12e-05 | 105 | 227 | 8 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 3.18e-05 | 144 | 227 | 9 | GO:0043244 | |
| GeneOntologyBiologicalProcess | adherens junction maintenance | 1.05e-04 | 9 | 227 | 3 | GO:0034334 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | MAP1A KATNB1 MTSS1 CRACD SVIL LIMA1 RB1 EML4 PPFIA1 CAMSAP3 TRIOBP COLGALT1 AKAP9 ARHGEF10 LIMCH1 | 1.10e-04 | 438 | 227 | 15 | GO:1902903 |
| GeneOntologyCellularComponent | microtubule organizing center | TTLL9 KATNB1 CDH23 DENND1C SGO1 BRCA1 STARD9 CDC16 LEO1 EML4 CAMSAP3 TOPBP1 TRIOBP SPAG9 DZANK1 C2CD3 AKAP9 ARHGEF10 TTLL6 KIAA1217 TTLL4 DYNC1LI1 ATM CSPP1 G6PD | 4.28e-05 | 919 | 235 | 25 | GO:0005815 |
| Domain | ANK | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 1.71e-08 | 251 | 232 | 17 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 1.92e-08 | 253 | 232 | 17 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 2.04e-08 | 254 | 232 | 17 | PS50297 |
| Domain | Ank | ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 2.77e-08 | 228 | 232 | 16 | PF00023 |
| Domain | Ankyrin_rpt | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 3.21e-08 | 262 | 232 | 17 | IPR002110 |
| Domain | Ank_2 | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG ANKRD6 POTEC POTEM ANKRD17 POTEJ POTEI | 8.22e-08 | 215 | 232 | 15 | PF12796 |
| Domain | - | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 8.93e-08 | 248 | 232 | 16 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 1.24e-07 | 254 | 232 | 16 | IPR020683 |
| Domain | BRCT | 2.86e-06 | 19 | 232 | 5 | PF00533 | |
| Domain | BRCT | 6.28e-06 | 22 | 232 | 5 | SM00292 | |
| Domain | - | 7.94e-06 | 23 | 232 | 5 | 3.40.50.10190 | |
| Domain | BRCT | 1.51e-05 | 26 | 232 | 5 | PS50172 | |
| Domain | BRCT_dom | 2.20e-05 | 28 | 232 | 5 | IPR001357 | |
| Domain | RIH_assoc-dom | 3.68e-05 | 6 | 232 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.68e-05 | 6 | 232 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.68e-05 | 6 | 232 | 3 | PF08454 | |
| Domain | RIH_dom | 3.68e-05 | 6 | 232 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.68e-05 | 6 | 232 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.68e-05 | 6 | 232 | 3 | IPR015925 | |
| Domain | - | 3.68e-05 | 6 | 232 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.68e-05 | 6 | 232 | 3 | PF01365 | |
| Domain | Actin_CS | 3.75e-05 | 16 | 232 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 4.86e-05 | 17 | 232 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 6.19e-05 | 18 | 232 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 7.77e-05 | 19 | 232 | 4 | PS01132 | |
| Domain | INT_SG_DDX_CT_C | 1.01e-04 | 8 | 232 | 3 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 1.01e-04 | 8 | 232 | 3 | IPR029307 | |
| Domain | MIR | 2.13e-04 | 10 | 232 | 3 | PF02815 | |
| Domain | MIR_motif | 2.13e-04 | 10 | 232 | 3 | IPR016093 | |
| Domain | MIR | 2.13e-04 | 10 | 232 | 3 | PS50919 | |
| Domain | MIR | 2.13e-04 | 10 | 232 | 3 | SM00472 | |
| Domain | DUF4592 | 4.57e-04 | 3 | 232 | 2 | IPR028030 | |
| Domain | Ryanodine_rcpt | 4.57e-04 | 3 | 232 | 2 | IPR003032 | |
| Domain | DUF4592 | 4.57e-04 | 3 | 232 | 2 | PF15262 | |
| Domain | Ryanrecept_TM4-6 | 4.57e-04 | 3 | 232 | 2 | IPR009460 | |
| Domain | RyR | 4.57e-04 | 3 | 232 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 4.57e-04 | 3 | 232 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.57e-04 | 3 | 232 | 2 | IPR013333 | |
| Domain | TTL | 4.94e-04 | 13 | 232 | 3 | PS51221 | |
| Domain | TTL/TTLL_fam | 4.94e-04 | 13 | 232 | 3 | IPR004344 | |
| Domain | TTL | 4.94e-04 | 13 | 232 | 3 | PF03133 | |
| Domain | ATP_grasp_subdomain_2 | 5.61e-04 | 31 | 232 | 4 | IPR013816 | |
| Domain | Actin | 5.61e-04 | 31 | 232 | 4 | IPR004000 | |
| Domain | Actin | 5.61e-04 | 31 | 232 | 4 | PF00022 | |
| Domain | ACTIN | 5.61e-04 | 31 | 232 | 4 | SM00268 | |
| Domain | NPIP | 6.22e-04 | 14 | 232 | 3 | IPR009443 | |
| Domain | PTCB-BRCT | 9.07e-04 | 4 | 232 | 2 | PF12738 | |
| Domain | WD40_repeat_dom | KATNB1 DMXL1 WDR44 BRWD1 EML4 WDR70 SPAG9 PPWD1 ARHGEF10 LRBA CFAP44 | 1.27e-03 | 297 | 232 | 11 | IPR017986 |
| Domain | - | 1.78e-03 | 70 | 232 | 5 | 2.10.110.10 | |
| Domain | LIM | 1.89e-03 | 71 | 232 | 5 | SM00132 | |
| Domain | Znf_LIM | 1.89e-03 | 71 | 232 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.89e-03 | 71 | 232 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.89e-03 | 71 | 232 | 5 | PS50023 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZC3H13 USP19 MYO3A ZNF644 SVIL AFDN WDR44 LIMA1 HIRIP3 LEO1 EML4 CAMSAP3 KLC2 DIDO1 SPAG9 ZC3H18 THOC2 ATAD2 EIF2D PAXBP1 ZNF516 DYNC1LI1 ANKRD17 DDX20 LIMCH1 ATM TP53BP1 | 7.24e-12 | 774 | 241 | 27 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 MAP1A ZNF180 SGO1 TRIP11 POTEE PRRC2C ZNF644 GOLGB1 LEO1 RB1 TOPBP1 KLC2 ZC3H18 KIAA1217 ZNF516 DDX20 POTEJ POTEI CFAP44 TRIM37 TP53BP1 | 1.90e-10 | 588 | 241 | 22 | 38580884 |
| Pubmed | 3.18e-10 | 7 | 241 | 5 | 15276201 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 4.94e-10 | 15 | 241 | 6 | 16824795 | |
| Pubmed | 8.44e-10 | 8 | 241 | 5 | 12475935 | ||
| Pubmed | TRIP11 PTPRD ATXN2 PRRC2C SVIL AFDN UNC79 GOLGB1 VGF CACNA1E LIMA1 FXR2 PPFIA1 CAMSAP3 TRIOBP DIDO1 DZANK1 TXLNA AKAP9 KIAA1217 ZNF516 ANKRD17 LIMCH1 FRMPD3 CDC5L CTNND1 TP53BP1 | 9.22e-10 | 963 | 241 | 27 | 28671696 | |
| Pubmed | 1.89e-09 | 9 | 241 | 5 | 16364570 | ||
| Pubmed | TMEM94 MCAM ITGA6 TRIP11 ARL13B DMD GOLGB1 TOR1AIP2 CCDC28A PPFIA1 TRIOBP CBLB ARHGAP5 ARHGEF10 KIAA1217 LRBA CTNND1 | 7.76e-09 | 421 | 241 | 17 | 36976175 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 KIAA0232 TRIP11 FSIP2 STARD9 PRRC2C PI4KB SVIL AFDN GOLGB1 LIMA1 POTEF PPFIA1 CAMSAP3 KLC2 C2CD3 AKAP9 ARHGEF10 KIAA1217 ANKRD17 LIMCH1 CTNND1 EIF4G3 CSPP1 | 9.38e-09 | 861 | 241 | 24 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF131 CHD2 SGO1 CASZ1 FSIP2 BRCA1 SATB1 ZNF644 PDS5A MBD4 ASF1A BRWD1 HIRIP3 RB1 DHX37 WDR70 TOPBP1 DIDO1 ZC3H18 ATAD2 | 1.16e-08 | 608 | 241 | 20 | 36089195 |
| Pubmed | POTEB3 POTEE POTEH TUT4 POTEF POTEG RGS10 POTEC POTEM POTEJ POTEI | 2.14e-08 | 163 | 241 | 11 | 24316575 | |
| Pubmed | RALGAPA1 MCAM ITGA6 SIX4 SGO1 ITPR3 PTPN12 PTPRD ATXN2 SVIL ARL13B DMD TOR1AIP2 LEO1 PPFIA1 CAMSAP3 TRIOBP SPAG9 COLGALT1 ARHGAP5 C2CD3 AKAP9 CDC5L CTNND1 CSPP1 G6PD | 2.37e-08 | 1049 | 241 | 26 | 27880917 | |
| Pubmed | BRCT repeats as phosphopeptide-binding modules involved in protein targeting. | 3.34e-08 | 6 | 241 | 4 | 14576432 | |
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 17171436 | ||
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | 4.35e-08 | 15 | 241 | 5 | 15905330 | |
| Pubmed | MCAM ITGA6 TRIP11 PI4KB ARL13B GOLGB1 WDR44 RAB25 ARHGEF10 SPRED1 LRBA CTNND1 G6PD PCMT1 | 1.28e-07 | 339 | 241 | 14 | 37232246 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF131 SIX4 CASZ1 XYLT1 CRACD SATB1 PRRC2C ZNF644 PDS5A ANKRD20A1 TCF4 RB1 WDR70 POLRMT AGGF1 DEPDC1 SPAG9 RFX3 PANK4 ANKRD17 CTNND1 TP53BP1 | 1.66e-07 | 857 | 241 | 22 | 25609649 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF131 MAP1A TRIP11 NSRP1 CRACD PTPN12 PRRC2C GOLGB1 WDR44 LIMA1 WDR70 DIDO1 SPAG9 THOC2 KIAA1217 ANKRD17 LRBA CDC5L CTNND1 EIF4G3 G6PD TP53BP1 PCMT1 | 1.79e-07 | 934 | 241 | 23 | 33916271 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 BDP1 KIAA0232 CHD2 PDE10A NSRP1 CASZ1 DNAH14 ZNF461 ATXN2 ZNF589 OSBPL5 KATNIP CLEC16A MAML3 GOLGB1 TUT4 RAB25 WDR70 CAMSAP3 TRIOBP AHCYL2 KIAA1217 PANK4 ANKRD17 LIMCH1 LRBA CTNND1 EIF4G3 LCOR | 1.79e-07 | 1489 | 241 | 30 | 28611215 |
| Pubmed | ZC3H13 CHD2 ITPR3 PRRC2C PDS5A AFDN FXR2 DHX37 POLRMT DIDO1 SPAG9 ZC3H18 THOC2 ATAD2 ANKRD17 DDX20 ATM EIF4G3 TP53BP1 | 1.83e-07 | 653 | 241 | 19 | 22586326 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TMEM94 F5 DMXL1 ATXN2 PRRC2C ASF1A CACNA1E WDR70 CAMSAP3 ARHGAP5 DYNC1LI1 DDX20 LIMCH1 CDC5L TP53BP1 PCMT1 | 2.56e-07 | 475 | 241 | 16 | 31040226 |
| Pubmed | TRIP11 NSRP1 ITPR3 PRRC2C SVIL GOLGB1 LIMA1 TRIOBP DIDO1 KIAA1217 DYNC1LI1 CDC5L G6PD TP53BP1 | 2.64e-07 | 360 | 241 | 14 | 33111431 | |
| Pubmed | A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. | 3.29e-07 | 3 | 241 | 3 | 11756551 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.29e-07 | 3 | 241 | 3 | 17101985 | |
| Pubmed | 4.29e-07 | 67 | 241 | 7 | 29254152 | ||
| Pubmed | ZC3H13 NSRP1 PTPN12 CDC16 AFDN WDR44 HIRIP3 LEO1 CAMSAP3 TOPBP1 KLC2 DIDO1 THOC2 DDX20 EIF4G3 TP53BP1 | 5.47e-07 | 503 | 241 | 16 | 16964243 | |
| Pubmed | MCAM TRIP11 USP19 RYR2 DMXL1 FAT1 BRCA1 PI4KB ARL13B PDS5A AFDN CLEC16A GOLGB1 HIRIP3 PPFIA1 PODXL2 SPAG9 LRBA CTNND1 EIF4G3 | 5.95e-07 | 777 | 241 | 20 | 35844135 | |
| Pubmed | TTLL9 CHD2 TRIP11 CASZ1 RYR1 RYR2 ITPR3 PI4KB FGD5 MAML3 TOR1AIP2 FXR2 ZNF516 PAXIP1 AGK ANKRD17 POTEJ CSPP1 | 6.05e-07 | 638 | 241 | 18 | 31182584 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KIAA0232 ZNF185 KATNB1 SVIL ARHGAP29 AFDN CLEC16A BRWD1 FXR2 DHX37 CAMSAP3 KLC2 CASP8 ARHGAP5 TXLNA EIF2D C2CD3 KIAA1217 DYNC1LI1 TRIM37 PCMT1 | 6.31e-07 | 853 | 241 | 21 | 28718761 |
| Pubmed | SGO1 F5 BRCA1 ASF1A HIRIP3 RB1 TOPBP1 SPAG9 THOC2 ATAD2 TXLNA C2CD3 ZNF516 PAXIP1 AGK LRBA CSPP1 LCOR | 7.07e-07 | 645 | 241 | 18 | 25281560 | |
| Pubmed | ZNF131 KLF12 ZSCAN5DP ZC3H13 ZNF180 IRF1 SIX4 SATB1 ZNF644 TCF4 IRF8 DIDO1 ATAD2 RFX3 ZNF496 ZSCAN5B ZNF516 RORA CDC5L LCOR | 1.09e-06 | 808 | 241 | 20 | 20412781 | |
| Pubmed | TMEM94 KIAA0232 USP19 CRACD STARD9 PRRC2C ZNF644 KATNIP CLEC16A AHCYL2 AKAP9 LIMCH1 ST18 PLCE1 | 1.14e-06 | 407 | 241 | 14 | 12693553 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 15456759 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 1.31e-06 | 4 | 241 | 3 | 7823961 | |
| Pubmed | 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. | 1.31e-06 | 4 | 241 | 3 | 23727112 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 17342726 | ||
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 26774285 | ||
| Pubmed | CFTR CHD2 SYNC PDE10A CMYA5 TRIP11 ZNF461 LRRC42 STARD9 CNGB1 TCF4 TUT4 TMEM233 ATAD2 CCDC7 AXDND1 DZANK1 SCG3 | 1.69e-06 | 686 | 241 | 18 | 29987050 | |
| Pubmed | 1.80e-06 | 118 | 241 | 8 | 30979931 | ||
| Pubmed | 2.13e-06 | 14 | 241 | 4 | 22346761 | ||
| Pubmed | 2.25e-06 | 31 | 241 | 5 | 19690177 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ZNF185 ITGA6 SCEL TRIP11 SVIL ARHGAP29 AFDN GOLGB1 LIMA1 KLC2 ARHGAP5 KIAA1217 SPRED1 LIMCH1 CTNND1 PCMT1 | 2.47e-06 | 565 | 241 | 16 | 25468996 |
| Pubmed | ZNF131 KLF12 IRF1 SIX4 FAT1 BRCA1 SATB1 ATXN2 PRRC2C ZNF644 SVIL PDS5A ASF1A TCF4 LIMA1 RB1 DHX37 IRF8 DIDO1 SPAG9 ZC3H18 ZNF516 PAXIP1 AGK ANKRD17 TP53BP1 PCMT1 | 2.60e-06 | 1429 | 241 | 27 | 35140242 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 38244928 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF131 ZC3H13 NSRP1 BRCA1 ATXN2 PRRC2C ZNF644 PDS5A AFDN MBD4 EML4 TOPBP1 CASP8 DIDO1 ZC3H18 FANCM THOC2 PAXBP1 CDC5L LCOR TP53BP1 | 3.66e-06 | 954 | 241 | 21 | 36373674 |
| Pubmed | SYNC NCAPH2 CMYA5 USP9Y TRIP11 ZKSCAN5 PTPRD SATB1 ARL13B AFDN MBD4 BRWD1 LEO1 TRIOBP ANKRD6 ARHGAP5 ARHGEF10 SCG3 SPRED1 ATM LRBA EIF4G3 ST18 LCOR TRIM37 | 3.77e-06 | 1285 | 241 | 25 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ZC3H13 CHD2 SYNC ANKRD20A3P DNAH14 RYR1 POTEE EDAR PDS5A RAB25 RB1 FXR2 CAMSAP3 SPAG9 ARHGAP5 ATM CFAP44 PCMT1 | 4.49e-06 | 736 | 241 | 18 | 29676528 |
| Pubmed | ITPR3 PTPN12 TCF4 CECR2 DIDO1 COLGALT1 AKAP9 PAXIP1 DYNC1LI1 DDX20 CDC5L TP53BP1 PCMT1 | 4.59e-06 | 396 | 241 | 13 | 26687479 | |
| Pubmed | CHD2 SIX4 CASZ1 GREB1L POTEE CRACD BRCA1 ATXN2 CDC16 PDS5A AFDN MBD4 ASF1A GOLGB1 PPFIA1 CAMSAP3 TOPBP1 POLRMT TRIOBP DIDO1 ATAD2 MRM3 PAXBP1 ANKRD17 DDX20 LIMCH1 EIF4G3 | 6.09e-06 | 1497 | 241 | 27 | 31527615 | |
| Pubmed | 6.38e-06 | 18 | 241 | 4 | 27001747 | ||
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 19716796 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.47e-06 | 6 | 241 | 3 | 25966694 | |
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 20519450 | ||
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 17293456 | ||
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 23463619 | ||
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 23990464 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.47e-06 | 6 | 241 | 3 | 16844763 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CMYA5 USP19 STARD9 CDC16 PDS5A AFDN FGD5 ASF1A DHX37 POLRMT COLGALT1 THOC2 ATAD2 MRM3 TXLNA PAXBP1 ANP32A AGK DYNC1LI1 PNPLA8 DDX20 ATM CDC5L CTNND1 G6PD PCMT1 | 7.48e-06 | 1425 | 241 | 26 | 30948266 |
| Pubmed | KLF12 USP45 ZC3H13 CHD2 GOLGB1 BRWD1 TOR1AIP2 PPFIA1 DIDO1 DEPDC1 GPR183 COLGALT1 ANKRD6 THOC2 ZNF496 ARHGAP5 PAXBP1 TTLL4 ANKRD17 SPRED1 TRIM37 TP53BP1 | 7.72e-06 | 1084 | 241 | 22 | 11544199 | |
| Pubmed | USP9Y POTEF PPFIA1 ZC3H18 THOC2 PAXBP1 DDX20 CDC5L CTNND1 PCMT1 | 8.81e-06 | 244 | 241 | 10 | 29884807 | |
| Pubmed | CHD2 PDE10A PLA2G4D SGO1 RYR2 POTEE BRCA1 STARD9 PRRC2C DMD GOLGB1 CACNA1E LIMA1 LEO1 POTEF PPFIA1 CAMSAP3 AHCYL2 C2CD3 SCG3 TNN LIMCH1 ATM POTEJ POTEI EIF4G3 | 9.20e-06 | 1442 | 241 | 26 | 35575683 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ZC3H13 CDH23 F5 FAT1 SYCP2 PRRC2C REV1 FXR2 RRM2B WDR70 DIDO1 ZC3H18 | 9.46e-06 | 361 | 241 | 12 | 26167880 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.05e-05 | 197 | 241 | 9 | 20811636 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 CHD2 USP9Y DHX37 PPFIA1 CAMSAP3 POLRMT KLC2 LIMCH1 ATM LRBA CTNND1 CSPP1 G6PD | 1.13e-05 | 497 | 241 | 14 | 36774506 |
| Pubmed | ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication. | 1.13e-05 | 7 | 241 | 3 | 34144977 | |
| Pubmed | 1.13e-05 | 7 | 241 | 3 | 11860456 | ||
| Pubmed | IL16 MAP1A SCEL ZKSCAN5 NSRP1 ZNF461 FAT1 BRCA1 CDC16 ZNF589 BRWD1 TOR1AIP2 TUT4 RB1 FXR2 CECR2 PPFIA1 POLRMT ZC3H18 PANK4 ANKRD17 LCOR | 1.21e-05 | 1116 | 241 | 22 | 31753913 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.23e-05 | 153 | 241 | 8 | 26365490 | |
| Pubmed | RALGAPA1 ZNF131 ZC3H13 NSRP1 DMXL1 ITPR3 ZNF644 ARL13B GOLGB1 TOR1AIP2 PPFIA1 POLRMT TRIOBP COLGALT1 TXLNA PAXBP1 AKAP9 ARHGEF10 PANK4 PNPLA8 ATM CDC5L CTNND1 EIF4G3 CSPP1 TP53BP1 | 1.56e-05 | 1487 | 241 | 26 | 33957083 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.79e-05 | 8 | 241 | 3 | 12634303 | |
| Pubmed | ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis. | 1.79e-05 | 8 | 241 | 3 | 32051414 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.79e-05 | 8 | 241 | 3 | 19033399 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | POTEE LIMA1 FXR2 POTEF DIDO1 COLGALT1 THOC2 POTEJ POTEI TP53BP1 | 2.18e-05 | 271 | 241 | 10 | 32433965 |
| Pubmed | 2.68e-05 | 9 | 241 | 3 | 23901102 | ||
| Pubmed | 2.68e-05 | 9 | 241 | 3 | 19531582 | ||
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 2.68e-05 | 9 | 241 | 3 | 33479228 | |
| Pubmed | CHD2 HELB PTPN12 PRRC2C PDS5A TTC5 UNC79 CECR2 ZC3H18 PAXBP1 CDC5L LCOR TP53BP1 | 2.74e-05 | 469 | 241 | 13 | 27634302 | |
| Pubmed | 3.80e-05 | 10 | 241 | 3 | 18434328 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H13 CHD2 NCAPH2 SIX4 CASZ1 ITPR3 ZNF276 BRCA1 CDC16 ZNF644 PDS5A MBD4 HIRIP3 LEO1 TOPBP1 DIDO1 ZC3H18 FANCM THOC2 PAXBP1 PAXIP1 CDC5L LCOR | 3.86e-05 | 1294 | 241 | 23 | 30804502 |
| Pubmed | KLF12 ZNF185 IRF1 SIX4 ZKSCAN5 ZNF276 BRCA1 SATB1 AFDN LHX5 MAML3 TCF4 AGGF1 DIDO1 RORA LCOR | 4.05e-05 | 709 | 241 | 16 | 22988430 | |
| Pubmed | ZNF185 TMTC2 TRIP11 ITPR3 BRCA1 SVIL PDS5A MBD4 RB1 FXR2 POLRMT CASP8 ZC3H18 CTNND1 LCOR | 4.15e-05 | 634 | 241 | 15 | 34591612 | |
| Pubmed | 4.66e-05 | 29 | 241 | 4 | 33278357 | ||
| Pubmed | Development of CD30+ lymphoproliferative disease in mice lacking interferon regulatory factor-1. | 4.78e-05 | 2 | 241 | 2 | 13679855 | |
| Pubmed | ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | 4.78e-05 | 2 | 241 | 2 | 39083600 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 12570871 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 26555638 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 12364621 | ||
| Pubmed | Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity. | 4.78e-05 | 2 | 241 | 2 | 21849032 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 32455610 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 23653363 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 24680865 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 11704837 | ||
| Pubmed | Replicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells. | 4.78e-05 | 2 | 241 | 2 | 33811064 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 15684034 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 25940130 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 4.78e-05 | 2 | 241 | 2 | 14722100 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 4.78e-05 | 2 | 241 | 2 | 19669888 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 4.78e-05 | 2 | 241 | 2 | 26009179 | |
| Pubmed | Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. | 4.78e-05 | 2 | 241 | 2 | 12810625 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 23858098 | ||
| Interaction | POTEC interactions | 2.36e-07 | 13 | 233 | 5 | int:POTEC | |
| Interaction | DYRK1A interactions | RALGAPA1 BDP1 KIAA0232 NCAPH2 BRCA1 CLEC16A GOLGB1 LEO1 RB1 PPFIA1 WDR70 TRIOBP TXLNA KIAA1217 SPRED1 LIMCH1 LRBA CTNND1 EIF4G3 G6PD PCMT1 | 1.93e-06 | 552 | 233 | 21 | int:DYRK1A |
| Interaction | POTED interactions | 6.05e-06 | 4 | 233 | 3 | int:POTED | |
| Interaction | POTEG interactions | 8.01e-06 | 12 | 233 | 4 | int:POTEG | |
| Interaction | C2CD4B interactions | 1.09e-05 | 44 | 233 | 6 | int:C2CD4B | |
| Interaction | DYNLL2 interactions | ANKRD20A2P PTPN12 ANKRD20A4P ANKRD20A1 GOLGB1 EML4 AGGF1 ZC3H18 DZANK1 AKAP9 PAXIP1 DYNC1LI1 TP53BP1 | 1.26e-05 | 263 | 233 | 13 | int:DYNLL2 |
| Interaction | ACTG2 interactions | 2.07e-05 | 49 | 233 | 6 | int:ACTG2 | |
| Interaction | ACTB interactions | MAP1A CFTR NSRP1 FSIP2 POTEE CRACD ATXN2 SVIL PDS5A FGD5 CLEC16A WDR44 LIMA1 LEO1 POTEF PPFIA1 AHCYL2 COLGALT1 ANP32A DYNC1LI1 PNPLA8 LIMCH1 POTEJ CDC5L CTNND1 POTEI LCOR G6PD TRIM37 | 2.24e-05 | 1083 | 233 | 29 | int:ACTB |
| Interaction | ANKRD20A4P interactions | 2.97e-05 | 6 | 233 | 3 | int:ANKRD20A4P | |
| Interaction | AKAP6 interactions | 3.68e-05 | 17 | 233 | 4 | int:AKAP6 | |
| Interaction | ANKRD20A2P interactions | 5.16e-05 | 7 | 233 | 3 | int:ANKRD20A2P | |
| Interaction | PSMD1 interactions | BDP1 CFTR BRCA1 PDS5A AFDN FGD5 MBD4 CACNA1E LIMA1 LEO1 PPFIA1 KLC2 SPAG9 CBLB PPWD1 CDC5L | 6.04e-05 | 442 | 233 | 16 | int:PSMD1 |
| Interaction | DCLRE1A interactions | 7.29e-05 | 20 | 233 | 4 | int:DCLRE1A | |
| Interaction | ATG16L1 interactions | MAP1A ZC3H13 ZNF185 TRIP11 NSRP1 RYR2 ITPR3 PRRC2C ARL13B KATNIP ASF1A GOLGB1 REV1 LIMA1 EML4 RRM2B PPFIA1 WDR70 TRIOBP TXLNA EIF2D TTLL6 KIAA1217 TTLL4 AGK ATM CTNND1 CSPP1 TRIM37 | 7.81e-05 | 1161 | 233 | 29 | int:ATG16L1 |
| Interaction | YWHAH interactions | RALGAPA1 KIAA0232 ZC3H13 CFTR TRIP11 STARD9 PRRC2C PI4KB SVIL OSBPL5 AFDN CLEC16A LIMA1 FXR2 POTEF PPFIA1 CAMSAP3 KLC2 C2CD3 AKAP9 KIAA1217 ANKRD17 LIMCH1 LRBA CTNND1 EIF4G3 CSPP1 G6PD | 7.83e-05 | 1102 | 233 | 28 | int:YWHAH |
| Interaction | CDH1 interactions | CFTR ZNF185 ITGA6 TMTC2 SCEL TRIP11 PTPRD BRCA1 SVIL ARHGAP29 AFDN GOLGB1 LIMA1 RAB25 KLC2 CASP8 ARHGAP5 KIAA1217 SPRED1 LIMCH1 CTNND1 PCMT1 | 8.90e-05 | 768 | 233 | 22 | int:CDH1 |
| Interaction | PFN1 interactions | MAP1A CFTR TRIP11 BRCA1 ARHGAP29 AFDN GOLGB1 WDR44 ZC3H18 ARHGAP5 AKAP9 KIAA1217 DYNC1LI1 DDX20 LIMCH1 TRIM37 TP53BP1 | 9.55e-05 | 509 | 233 | 17 | int:PFN1 |
| Interaction | KDM1A interactions | ZNF131 IL16 GREB1L BRCA1 SATB1 ZNF644 ARHGAP29 PDS5A MBD4 GOLGB1 TCF4 LEO1 RB1 EML4 PPFIA1 CAMSAP3 POLRMT THOC2 AKAP9 KIAA1217 ZNF516 ANKRD17 LRBA CDC5L TP53BP1 | 9.70e-05 | 941 | 233 | 25 | int:KDM1A |
| Interaction | CAMK2G interactions | RYR1 USP19 ITPR3 ARHGAP29 TTC5 CLEC16A SHISA6 FXR2 ZC3H18 THOC2 TRIM37 | 1.16e-04 | 240 | 233 | 11 | int:CAMK2G |
| Interaction | ACTG1 interactions | MAP1A CFTR POTEE PTPN12 BRCA1 WDR44 LIMA1 POTEF TOPBP1 KLC2 ZC3H18 DYNC1LI1 PNPLA8 POTEJ CTNND1 POTEI G6PD | 1.24e-04 | 520 | 233 | 17 | int:ACTG1 |
| Interaction | KIF2A interactions | MAP1A BRCA1 KATNIP CLEC16A WDR44 FAM13C FXR2 EML4 CAMSAP3 KLC2 TRIOBP | 1.25e-04 | 242 | 233 | 11 | int:KIF2A |
| Interaction | CSNK2B interactions | USP45 KIAA0232 IRF1 ITPR3 PTPN12 BRCA1 ZNF644 PDS5A MBD4 HIRIP3 LEO1 FXR2 DIDO1 ZC3H18 ATAD2 ZNF496 ZNF516 PAXIP1 CDC5L | 1.28e-04 | 625 | 233 | 19 | int:CSNK2B |
| Interaction | YWHAZ interactions | RALGAPA1 BDP1 KIAA0232 CFTR FSIP2 CRACD MYO3A BRCA1 STARD9 PI4KB ZNF644 SVIL ARHGAP29 AFDN KATNIP LIMA1 POTEF PPFIA1 CAMSAP3 KLC2 ZC3H18 TXLNA AKAP9 DYNC1LI1 ANKRD17 ATM CDC5L CTNND1 G6PD TRIM37 TP53BP1 | 1.32e-04 | 1319 | 233 | 31 | int:YWHAZ |
| Interaction | POTEH interactions | 1.33e-04 | 2 | 233 | 2 | int:POTEH | |
| Interaction | DCLRE1C interactions | 1.33e-04 | 43 | 233 | 5 | int:DCLRE1C | |
| Interaction | JPH4 interactions | 1.35e-04 | 68 | 233 | 6 | int:JPH4 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.84e-16 | 13 | 160 | 9 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD20A2P ANKRD20A3P POTEE ANKRD20A4P POTEH ANKRD20A1 POTEF POTEG POTED ANKRD6 POTEC DZANK1 POTEM ANKRD17 POTEJ POTEI | 4.74e-10 | 242 | 160 | 16 | 403 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.12e-04 | 181 | 160 | 8 | 694 | |
| GeneFamily | Tubulin tyrosine ligase family | 2.30e-04 | 14 | 160 | 3 | 779 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.32e-04 | 3 | 160 | 2 | 287 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 4.62e-04 | 4 | 160 | 2 | 1335 | |
| GeneFamily | WD repeat domain containing | 5.53e-04 | 262 | 160 | 9 | 362 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.36e-03 | 25 | 160 | 3 | 775 | |
| GeneFamily | LIM domain containing | 1.84e-03 | 59 | 160 | 4 | 1218 | |
| GeneFamily | Granins | 2.10e-03 | 8 | 160 | 2 | 925 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 3.34e-03 | 10 | 160 | 2 | 822 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NPIPB5 FAT1 PTPN12 BRCA1 ATXN2 PRRC2C ARHGAP29 PDS5A CLEC16A TUT4 RB1 PPFIA1 TOPBP1 CASP8 CBLB C2CD3 AKAP9 ANKRD17 LIMCH1 EIF4G3 G6PD TRIM37 PCMT1 | 6.22e-11 | 466 | 239 | 23 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ITGA6 NPIPB3 FAT1 PTPN12 BRCA1 ATXN2 PRRC2C CDC16 ARHGAP29 PDS5A DMD CLEC16A TUT4 RB1 PPFIA1 TOPBP1 CASP8 SPAG9 THOC2 CBLB C2CD3 AKAP9 ARHGEF10 ANKRD17 EIF4G3 TRIM37 TP53BP1 PCMT1 PLCE1 | 1.37e-09 | 856 | 239 | 29 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 ITGA6 NPIPB3 TRIP11 NSRP1 DMXL1 BRCA1 ZNF644 MBD4 GOLGB1 TCF4 LIMA1 TUT4 RRM2B PPFIA1 AGGF1 DEPDC1 ATAD2 PPWD1 ARHGAP5 RORA ATM CDC5L CSPP1 | 9.22e-09 | 656 | 239 | 24 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | RALGAPA1 KLF12 PDE10A DNAH14 SVIL ADAMTS17 CBLB ARHGAP5 KIAA1217 RORA LIMCH1 LRBA | 5.15e-07 | 208 | 239 | 12 | M39233 |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 2.27e-06 | 160 | 239 | 10 | M339 | |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | PDS5A GPNMB BRWD1 CCDC28A WDR70 FANCM RFX3 AKAP9 ANKRD17 RORA | 2.83e-06 | 164 | 239 | 10 | M8989 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_1_DN | 2.60e-05 | 64 | 239 | 6 | M2237 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | ZC3H13 PTPRD PRRC2C AFDN GOLGB1 SPAG9 THOC2 ZNF804B RORA CSPP1 | 3.83e-05 | 221 | 239 | 10 | M39222 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.33e-05 | 180 | 239 | 9 | M8239 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | KIAA0232 ZNF185 MTSS1 FAT1 PTPRD GPNMB CLEC16A CBLB RGS10 ARHGAP5 ZNF516 TRIM37 PCMT1 PLCE1 | 5.37e-05 | 437 | 239 | 14 | M4665 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | SIX4 SGO1 GREB1L BOK MBD4 UNC79 REV1 HIRIP3 TOPBP1 DEPDC1 FANCM ATAD2 RFX3 SCG3 PAXIP1 ST18 TRIM37 TP53BP1 | 5.78e-05 | 680 | 239 | 18 | MM456 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 ZC3H13 SGO1 NSRP1 XYLT1 CRACD PTPN12 BRCA1 PI4KB ZNF644 PDS5A DMD ASF1A BRWD1 TUT4 HIRIP3 LEO1 RB1 DEPDC1 FANCM THOC2 ATAD2 PPWD1 ARHGAP5 DZANK1 AKAP9 ANP32A PAXIP1 SPRED1 ATM CDC5L CSPP1 TRIM37 TP53BP1 | 9.44e-07 | 1257 | 232 | 34 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ZC3H13 ITGA6 GBP1 CHD2 PDE10A RYR1 RYR2 DMXL1 GREB1L SYCP2 SATB1 ATXN2 PRRC2C ARHGAP29 SHISA6 WDR44 CCDC28A DIDO1 AHCYL2 THOC2 ANKRD17 SPRED1 CSPP1 LCOR STAG3 | 2.24e-06 | 795 | 232 | 25 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 PDE10A SGO1 PTPN12 DMRT3 BRCA1 PRRC2C PDS5A MAML3 WDR44 LEO1 DHX37 FANCM ATAD2 RFX3 SCG3 ANP32A PAXIP1 ATM | 6.72e-06 | 532 | 232 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 ZC3H13 SGO1 NSRP1 XYLT1 CRACD PTPN12 BRCA1 PI4KB ZNF644 PDS5A DMD ASF1A BRWD1 TUT4 HIRIP3 LEO1 RB1 CECR2 DEPDC1 FANCM THOC2 ATAD2 PPWD1 ARHGAP5 DZANK1 AKAP9 ANP32A PAXIP1 SPRED1 ATM CDC5L CSPP1 TRIM37 TP53BP1 | 9.35e-06 | 1459 | 232 | 35 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MAP1A ZC3H13 STAC3 DENND1C PDE10A SGO1 XYLT1 CRACD BRCA1 ZNF644 DMD BRWD1 TUT4 HIRIP3 KLC2 DEPDC1 ANKRD6 FANCM RFX3 ARHGAP5 DZANK1 AKAP9 TTLL4 ANP32A ATM CSPP1 TRIM37 TP53BP1 | 1.46e-05 | 1060 | 232 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 2.52e-05 | 79 | 232 | 7 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 SYN3 MAP1A STAC3 CHD2 PDE10A NSRP1 CRACD DMRT3 BRCA1 PDS5A LHX5 DMD MAML3 BRWD1 TUT4 HIRIP3 RB1 CECR2 CAMSAP3 AHCYL2 ANKRD6 AKAP9 SCG3 LRBA ST18 | 3.27e-05 | 989 | 232 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KLF12 MAP1A ZC3H13 TMTC2 SGO1 XYLT1 CRACD FAT1 BRCA1 SATB1 DMD MBD4 BRWD1 REV1 TUT4 HIRIP3 FXR2 KLC2 TRIOBP PODXL2 SPAG9 FANCM RFX3 DZANK1 AKAP9 TTLL4 ANP32A ATM CSPP1 TRIM37 TP53BP1 PLCE1 | 3.96e-05 | 1370 | 232 | 32 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | GPR155 MTSS1 DMXL1 ITPR3 XYLT1 BRWD1 CACNA1E TCF4 TUT4 EML4 CECR2 IRF8 GPR183 FANCM | 4.68e-05 | 361 | 232 | 14 | GSM538219_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 ZC3H13 CHD2 ZKSCAN5 NSRP1 MAML3 ASF1A GOLGB1 BRWD1 TOPBP1 DIDO1 FANCM THOC2 ARHGAP5 ANKRD17 SPRED1 PNPLA8 CSPP1 | 5.18e-05 | 564 | 232 | 18 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 SGO1 ZKSCAN5 NSRP1 DMXL1 MYO3A PRRC2C PDS5A MAML3 TCF4 DHX37 DEPDC1 FANCM AKAP9 ANP32A CTNND1 | 6.28e-05 | 469 | 232 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | B cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3 | GPR155 MTSS1 DMXL1 ITPR3 XYLT1 BRWD1 REV1 CACNA1E TUT4 EML4 CECR2 RRM2B IRF8 COLGALT1 | 7.23e-05 | 376 | 232 | 14 | GSM399438_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | USP45 ZC3H13 ITGA6 CHD2 PDE10A RYR2 DMXL1 GREB1L SATB1 ATXN2 PRRC2C ARHGAP29 DIDO1 AHCYL2 THOC2 RFX3 KIAA1217 ANKRD17 SPRED1 CSPP1 LCOR STAG3 | 7.65e-05 | 804 | 232 | 22 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | GPR155 MTSS1 DMXL1 ITPR3 XYLT1 BRWD1 CACNA1E TCF4 TUT4 EML4 CECR2 IRF8 GPR183 | 9.77e-05 | 339 | 232 | 13 | GSM403988_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ZC3H13 ITGA6 CHD2 PDE10A RYR2 DMXL1 GREB1L SYCP2 ARHGAP29 SHISA6 WDR44 THOC2 LCOR STAG3 | 9.82e-05 | 387 | 232 | 14 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | GPR155 IL16 STAC3 SIX4 SGO1 GREB1L CRACD PTPN12 PI4KB ZNF644 LIMA1 TUT4 HIRIP3 EML4 KLC2 DEPDC1 ANKRD6 FANCM THOC2 ATAD2 RFX3 ARHGAP5 DZANK1 AKAP9 ANP32A SPRED1 PNPLA8 ATM LRBA | 1.09e-04 | 1252 | 232 | 29 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ZC3H13 ITGA6 GBP1 CHD2 PDE10A RYR2 DMXL1 GREB1L SYCP2 PTPN12 BRCA1 ARHGAP29 WDR44 AHCYL2 THOC2 ARHGAP5 ANKRD17 ATM CSPP1 LCOR STAG3 | 1.30e-04 | 776 | 232 | 21 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.93e-04 | 225 | 232 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | GPR155 MTSS1 DMXL1 ITPR3 XYLT1 BRWD1 CACNA1E TCF4 TUT4 EML4 CECR2 IRF8 GPR183 | 2.13e-04 | 367 | 232 | 13 | GSM399440_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | ZC3H13 ITGA6 CHD2 PDE10A RYR2 DMXL1 GREB1L SYCP2 ARHGAP29 AHCYL2 THOC2 LCOR STAG3 | 3.55e-04 | 387 | 232 | 13 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ZC3H13 ITGA6 CHD2 PDE10A RYR2 DMXL1 GREB1L SYCP2 SATB1 PRRC2C ARHGAP29 SHISA6 WDR44 AHCYL2 THOC2 ARHGAP5 SPRED1 CSPP1 LCOR STAG3 | 3.68e-04 | 778 | 232 | 20 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | MAP1A ZC3H13 STAC3 GBP1 DENND1C PDE10A SGO1 XYLT1 CRACD BRCA1 ZNF644 DMD BRWD1 TUT4 HIRIP3 CECR2 KLC2 DEPDC1 ANKRD6 FANCM RFX3 ARHGAP5 DZANK1 AKAP9 TTLL4 ANP32A ATM CSPP1 TRIM37 TP53BP1 | 3.74e-04 | 1414 | 232 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 3.93e-04 | 57 | 232 | 5 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_200 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 BDP1 KLF12 NPIPB4 SYTL2 CHD2 USP9Y NPIPB5 HELB PRRC2C ZNF644 GOLGB1 EML4 CASP8 CBLB AKAP9 RORA ATM LRBA | 2.19e-18 | 199 | 240 | 19 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | KLF12 SYTL2 USP9Y NPIPB5 CASZ1 HELB STARD9 CASP8 CBLB CCDC7 RORA ATM LRBA | 6.20e-11 | 197 | 240 | 13 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | RALGAPA1 NPIPB4 CHD2 HELB PRRC2C GOLGB1 TUT4 EML4 CBLB AKAP9 RORA ATM | 1.68e-10 | 171 | 240 | 12 | 2e9a20f8980b78325c52065a9c14ab3656267c05 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | NPIPB4 SYTL2 NPIPB5 HELB PRRC2C EML4 CASP8 RFX3 AKAP9 RORA ATM LRBA | 8.56e-10 | 197 | 240 | 12 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | CFTR MTSS1 F5 SVIL FGD5 SHISA6 TCF4 LIMA1 RGS10 SYTL5 LIMCH1 | 1.49e-09 | 163 | 240 | 11 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFTR RYR2 FAT1 SYCP2 PTPRD DMD UNC79 STAB2 CNTNAP4 ST18 PLCE1 | 5.32e-09 | 184 | 240 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFTR RYR2 FAT1 SYCP2 PTPRD DMD UNC79 STAB2 CNTNAP4 ST18 PLCE1 | 5.32e-09 | 184 | 240 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFTR RYR2 FAT1 SYCP2 PTPRD DMD UNC79 STAB2 CNTNAP4 ST18 PLCE1 | 5.32e-09 | 184 | 240 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | BDP1 ATXN2 PRRC2C AFDN GOLGB1 TUT4 EML4 WDR70 RFX3 AKAP9 LRBA | 8.75e-09 | 193 | 240 | 11 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | NPIPB4 SYTL2 USP9Y NPIPB5 BRWD1 EML4 RFX3 AKAP9 RORA ATM LRBA | 8.75e-09 | 193 | 240 | 11 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | BDP1 ZC3H13 CHD2 NSRP1 SYCP2 PRRC2C GOLGB1 DHX37 THOC2 AKAP9 CSPP1 | 1.08e-08 | 197 | 240 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | ZC3H13 GBP3 TRIP11 NSRP1 PRRC2C ZNF644 GOLGB1 BRWD1 LIMA1 AKAP9 LIMCH1 | 1.20e-08 | 199 | 240 | 11 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | SYTL2 MCAM RYR2 FAT1 STARD9 DMD TCF4 FAM13C PCDHA10 AOC3 PLCE1 | 1.27e-08 | 200 | 240 | 11 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SYTL2 MCAM RYR2 FAT1 STARD9 DMD TCF4 FAM13C PCDHA10 AOC3 PLCE1 | 1.27e-08 | 200 | 240 | 11 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 GBP1 CHD2 PRRC2C ZNF644 GOLGB1 CASP8 SPAG9 PAXBP1 AKAP9 ATM | 1.27e-08 | 200 | 240 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SYTL2 MCAM RYR2 FAT1 STARD9 DMD TCF4 FAM13C PCDHA10 AOC3 PLCE1 | 1.27e-08 | 200 | 240 | 11 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MTSS1 ITGA6 GBP3 TRIP11 PRRC2C ARHGAP29 IRF8 SPAG9 ARHGAP5 AKAP9 | 4.81e-08 | 178 | 240 | 10 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.25e-08 | 135 | 240 | 9 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 NPIPB4 CHD2 ZNF644 GOLGB1 EML4 CBLB RORA LRBA TP53BP1 | 8.04e-08 | 188 | 240 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MTSS1 DNAH14 GREB1L CRACD MYO3A FAT1 MAML3 SYTL5 CNTNAP4 FRMPD3 | 8.45e-08 | 189 | 240 | 10 | f0aaf2994d319a39877d2845eaab9f166adead4e |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.24e-07 | 197 | 240 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | ZC3H13 TRIP11 NSRP1 PRRC2C ZNF644 GOLGB1 LIMA1 THOC2 AKAP9 LIMCH1 | 1.37e-07 | 199 | 240 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.50e-07 | 162 | 240 | 9 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.76e-07 | 170 | 240 | 9 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.38e-07 | 181 | 240 | 9 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.99e-07 | 183 | 240 | 9 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.99e-07 | 183 | 240 | 9 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-07 | 184 | 240 | 9 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-07 | 186 | 240 | 9 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.37e-07 | 187 | 240 | 9 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.75e-07 | 188 | 240 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-07 | 188 | 240 | 9 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-07 | 191 | 240 | 9 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.24e-06 | 145 | 240 | 8 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.29e-06 | 197 | 240 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 197 | 240 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 1.29e-06 | 197 | 240 | 9 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 198 | 240 | 9 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 198 | 240 | 9 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.37e-06 | 147 | 240 | 8 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-06 | 199 | 240 | 9 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.68e-06 | 151 | 240 | 8 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.26e-06 | 165 | 240 | 8 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-06 | 175 | 240 | 8 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 176 | 240 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.25e-06 | 176 | 240 | 8 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 5.55e-06 | 126 | 240 | 7 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.94e-06 | 179 | 240 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.19e-06 | 180 | 240 | 8 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.19e-06 | 180 | 240 | 8 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 6.45e-06 | 181 | 240 | 8 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 181 | 240 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.45e-06 | 181 | 240 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 6.71e-06 | 182 | 240 | 8 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 182 | 240 | 8 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 182 | 240 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A4P ANKRD20A1 RGS10 ARHGAP5 ZNF516 ST18 | 7.27e-06 | 184 | 240 | 8 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-06 | 185 | 240 | 8 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-06 | 185 | 240 | 8 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 7.57e-06 | 185 | 240 | 8 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 7.87e-06 | 186 | 240 | 8 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 186 | 240 | 8 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.87e-06 | 186 | 240 | 8 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 186 | 240 | 8 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-06 | 186 | 240 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.87e-06 | 186 | 240 | 8 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.19e-06 | 187 | 240 | 8 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.51e-06 | 188 | 240 | 8 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.16e-06 | 136 | 240 | 7 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.16e-06 | 136 | 240 | 7 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 190 | 240 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 190 | 240 | 8 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-06 | 190 | 240 | 8 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 190 | 240 | 8 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 9.19e-06 | 190 | 240 | 8 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 190 | 240 | 8 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.19e-06 | 190 | 240 | 8 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.27e-06 | 90 | 240 | 6 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.55e-06 | 191 | 240 | 8 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-06 | 191 | 240 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-06 | 191 | 240 | 8 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A4P ANKRD20A1 RGS10 ARHGAP5 ZNF516 ST18 | 9.55e-06 | 191 | 240 | 8 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-06 | 191 | 240 | 8 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-06 | 191 | 240 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.61e-06 | 137 | 240 | 7 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.92e-06 | 192 | 240 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A4P ANKRD20A1 RGS10 ARHGAP5 ZNF516 ST18 | 9.92e-06 | 192 | 240 | 8 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.92e-06 | 192 | 240 | 8 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-CD4_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.92e-06 | 192 | 240 | 8 | 28d6b159e29e6c45f3f27589bf981bab8e97068e | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 9.92e-06 | 192 | 240 | 8 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.01e-05 | 138 | 240 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 193 | 240 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 193 | 240 | 8 | c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 193 | 240 | 8 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 193 | 240 | 8 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-05 | 194 | 240 | 8 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 240 | 8 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 194 | 240 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-05 | 194 | 240 | 8 | 40c7f9bd69a8e843b81972e25a67f591021415dd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.03e-07 | 49 | 129 | 8 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-05 | 50 | 129 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | Joubert syndrome 1 | 1.38e-05 | 21 | 211 | 4 | C4551568 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.45e-05 | 152 | 211 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.52e-04 | 3 | 211 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.52e-04 | 3 | 211 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Multiple Sclerosis | 3.01e-04 | 45 | 211 | 4 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 3.01e-04 | 45 | 211 | 4 | C0751324 | |
| Disease | Rare disease with malignant hyperthermia | 3.02e-04 | 4 | 211 | 2 | cv:C5681128 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.21e-04 | 19 | 211 | 3 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | exercise test | 3.76e-04 | 20 | 211 | 3 | EFO_0004328 | |
| Disease | age at menarche | ZNF131 KLF12 CHD2 PTPRD BRCA1 SATB1 UNC79 BRWD1 TCF4 DZANK1 RORA EIF4G3 ST18 | 3.77e-04 | 594 | 211 | 13 | EFO_0004703 |
| Disease | kidney disease (biomarker_via_orthology) | 4.36e-04 | 21 | 211 | 3 | DOID:557 (biomarker_via_orthology) | |
| Disease | BREAST CANCER | 4.36e-04 | 21 | 211 | 3 | 114480 | |
| Disease | glaucoma | 8.69e-04 | 154 | 211 | 6 | MONDO_0005041 | |
| Disease | Malignant tumor of breast | 9.29e-04 | 27 | 211 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 9.29e-04 | 27 | 211 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 9.29e-04 | 27 | 211 | 3 | cv:C0346153 | |
| Disease | chronic mucus hypersecretion | 1.04e-03 | 7 | 211 | 2 | EFO_0005673 | |
| Disease | 1,5 anhydroglucitol measurement | 1.15e-03 | 29 | 211 | 3 | EFO_0008009 | |
| Disease | esophageal carcinoma | 1.27e-03 | 30 | 211 | 3 | EFO_0002916 | |
| Disease | Familial aplasia of the vermis | 1.27e-03 | 30 | 211 | 3 | C0431399 | |
| Disease | anthropometric measurement | 1.36e-03 | 168 | 211 | 6 | EFO_0004302 | |
| Disease | beta-secretase 1 measurement | 1.39e-03 | 8 | 211 | 2 | EFO_0009179 | |
| Disease | helix rolling | 1.39e-03 | 8 | 211 | 2 | EFO_0007670 | |
| Disease | serum IgG glycosylation measurement | KIAA0232 MTSS1 CHD2 RYR2 ADAMTS17 ARHGAP29 SHISA6 CACNA1E STAB2 DEPDC1 ZNF804B | 1.45e-03 | 523 | 211 | 11 | EFO_0005193 |
| Disease | Prostate cancer, familial | 1.53e-03 | 69 | 211 | 4 | C2931456 | |
| Disease | Leukemia, Myelocytic, Acute | 1.58e-03 | 173 | 211 | 6 | C0023467 | |
| Disease | lateral ventricle volume measurement | 1.68e-03 | 33 | 211 | 3 | EFO_0008487 | |
| Disease | urinary albumin to creatinine ratio | 1.88e-03 | 179 | 211 | 6 | EFO_0007778 | |
| Disease | lymphocyte count | ZNF131 KLF12 IL16 KIAA0232 CDH23 IRF1 CASZ1 PTPN12 ATXN2 ZNF644 CLEC16A TCF4 LIMA1 IL31RA RB1 POTEF PPFIA1 CASP8 ATM CDC5L PLCE1 | 1.97e-03 | 1464 | 211 | 21 | EFO_0004587 |
| Disease | electroencephalogram measurement | 1.98e-03 | 74 | 211 | 4 | EFO_0004357 | |
| Disease | Bipolar Disorder | 2.42e-03 | 477 | 211 | 10 | C0005586 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.68e-03 | 11 | 211 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.68e-03 | 11 | 211 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Cognitive impairment | 2.68e-03 | 11 | 211 | 2 | HP_0100543 | |
| Disease | Nonsyndromic Deafness | 2.75e-03 | 81 | 211 | 4 | C3711374 | |
| Disease | Antihypertensive use measurement | 3.09e-03 | 265 | 211 | 7 | EFO_0009927 | |
| Disease | monocyte count | RALGAPA1 CDH23 DENND1C CASZ1 RYR1 ZNF276 ATXN2 TCF4 STAB2 FXR2 CECR2 TMEM233 IRF8 CASP8 DIDO1 ZNF516 ATM CDC5L PLCE1 | 3.10e-03 | 1320 | 211 | 19 | EFO_0005091 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.15e-03 | 41 | 211 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.15e-03 | 41 | 211 | 3 | C0858252 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.20e-03 | 12 | 211 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | outer ear morphology trait | 3.20e-03 | 12 | 211 | 2 | EFO_0007664 | |
| Disease | Dental enamel hypoplasia | 3.20e-03 | 12 | 211 | 2 | EFO_1001304 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.27e-03 | 85 | 211 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.31e-03 | 139 | 211 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Vertigo | 3.31e-03 | 139 | 211 | 5 | HP_0002321 | |
| Disease | optic disc size measurement | 3.68e-03 | 205 | 211 | 6 | EFO_0004832 | |
| Disease | esophageal squamous cell carcinoma | 3.77e-03 | 13 | 211 | 2 | EFO_0005922 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.77e-03 | 13 | 211 | 2 | C1846647 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.10e-03 | 45 | 211 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | migraine disorder | 4.34e-03 | 357 | 211 | 8 | MONDO_0005277 | |
| Disease | Neoplasm of lung | 4.38e-03 | 14 | 211 | 2 | cv:C0024121 | |
| Disease | cerebellum cortex volume change measurement | 4.38e-03 | 14 | 211 | 2 | EFO_0021497 | |
| Disease | Lung cancer | 4.38e-03 | 14 | 211 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 4.38e-03 | 14 | 211 | 2 | 211980 | |
| Disease | Gastrointestinal Stromal Sarcoma | 4.64e-03 | 47 | 211 | 3 | C3179349 | |
| Disease | Malignant neoplasm of breast | SIX4 PTPRD BRCA1 ZNF644 ARHGAP29 FGD5 GPNMB DMD GOLGB1 RB1 IRF8 CASP8 AKAP9 ATM LRBA TP53BP1 | 4.70e-03 | 1074 | 211 | 16 | C0006142 |
| Disease | Squamous cell carcinoma of esophagus | 4.87e-03 | 95 | 211 | 4 | C0279626 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 4.87e-03 | 95 | 211 | 4 | EFO_0803331 | |
| Disease | Alzheimer's disease biomarker measurement | 4.92e-03 | 48 | 211 | 3 | EFO_0006514 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 5.03e-03 | 15 | 211 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.03e-03 | 15 | 211 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 5.03e-03 | 15 | 211 | 2 | C0154017 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 5.03e-03 | 15 | 211 | 2 | EFO_0007236 | |
| Disease | Carcinoma in situ of bladder | 5.03e-03 | 15 | 211 | 2 | C0154091 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.10e-03 | 447 | 211 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Gastrointestinal Stromal Tumors | 5.52e-03 | 50 | 211 | 3 | C0238198 | |
| Disease | osteosarcoma (is_implicated_in) | 5.72e-03 | 16 | 211 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.72e-03 | 16 | 211 | 2 | C0334634 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 5.83e-03 | 51 | 211 | 3 | cv:CN043650 | |
| Disease | response to tenofovir | 5.83e-03 | 51 | 211 | 3 | EFO_0009279 | |
| Disease | Adenoid Cystic Carcinoma | 5.84e-03 | 100 | 211 | 4 | C0010606 | |
| Disease | gastroesophageal reflux disease | 6.05e-03 | 101 | 211 | 4 | EFO_0003948 | |
| Disease | Benign neoplasm of stomach | 6.45e-03 | 17 | 211 | 2 | C0153943 | |
| Disease | Muscle hypotonia | 6.45e-03 | 17 | 211 | 2 | C0026827 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.45e-03 | 17 | 211 | 2 | C0496905 | |
| Disease | plasma protease C1 inhibitor measurement | 6.45e-03 | 17 | 211 | 2 | EFO_0008261 | |
| Disease | Carcinoma in situ of stomach | 6.45e-03 | 17 | 211 | 2 | C0154060 | |
| Disease | IGFBP-3 measurement | 6.84e-03 | 54 | 211 | 3 | EFO_0004626 | |
| Disease | Acute Cerebrovascular Accidents | 6.84e-03 | 54 | 211 | 3 | C0751956 | |
| Disease | Hepatomegaly | 6.84e-03 | 54 | 211 | 3 | C0019209 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVDSLPASDDKDLNV | 281 | Q5TYW2 | |
| NLPESDSESTQNEKR | 1261 | Q68DN1 | |
| QELQSKPDRSAEESD | 1541 | P55196 | |
| EKESETSSQKAPDAR | 541 | Q5RHP9 | |
| TSSQKAPDARDNVKD | 546 | Q5RHP9 | |
| SDKEERTDAAPKSQQ | 2471 | A6H8Y1 | |
| ESSLRATQPSENDKL | 1081 | Q99996 | |
| TTRNNQLDPTSKEDF | 316 | Q53H12 | |
| EFLKQEQEASPDRTT | 541 | O15013 | |
| KAAQRDNEEETTDDP | 106 | Q99459 | |
| QAREDKSLSEAPEDT | 231 | P41214 | |
| PSVDSADNLSEKLER | 41 | P13569 | |
| AAEDPVLTNSERNKV | 1171 | Q15878 | |
| AEKSQADSEVPDENL | 596 | Q96M83 | |
| SQDRSLDLTVKEPSN | 926 | Q86V15 | |
| RVDSLPASDDKDLNV | 281 | Q4UJ75 | |
| NTEKLEDAESSNPNL | 156 | Q9Y294 | |
| NDRNSSDETFLKDLP | 246 | Q14956 | |
| IDDREPLANAIKSDS | 1226 | Q9C0A0 | |
| ETASSPKSQREINAD | 111 | P0DMU8 | |
| PDSSATNEEKDLNSE | 281 | Q8N302 | |
| LASQANRKEEEAVEP | 101 | P09681 | |
| QQLKNEDETDRPSLE | 326 | Q3SXY8 | |
| PSDVKELVLDNSRSN | 16 | P39687 | |
| STLVGDKRSDPEQNE | 1131 | Q6PL18 | |
| QLKDSESTPVDDRIS | 681 | Q9UHI6 | |
| DIRPKVDSTRDQAAN | 1726 | P11532 | |
| DIEAQSERTKDTPLS | 1141 | O75179 | |
| KDSRSQLIPSESDQE | 636 | Q8IV53 | |
| DAFDRSPTDKELVAQ | 16 | Q9UMX3 | |
| QEKTEQEAAQRASPA | 181 | Q9P1Y5 | |
| AKDDTDRLVPNQEDA | 2216 | Q9H251 | |
| TDEENTKPRVIDLSQ | 1461 | Q9Y485 | |
| LSEKQEENSLASEPQ | 216 | Q9BXF3 | |
| RSSKSESRSPVQEDN | 26 | Q96MT7 | |
| ETASSPKSQREINAD | 111 | P0DMV0 | |
| RTAENQSEPEKPQDS | 786 | Q8TE56 | |
| DTPSSEQAVARKEEA | 306 | Q9Y2G4 | |
| QLAVTQRKEEEPSSS | 631 | Q16853 | |
| SADDNLKTPSERQLT | 506 | Q92617 | |
| SADDNLKTPSERQLT | 836 | Q92617 | |
| FETQRTPRKSNLDEE | 351 | P06400 | |
| KSDLSQAREVPTEEA | 126 | P57735 | |
| DKERNQEKPSNSESS | 481 | Q9H0G5 | |
| NIKLTRDAQSPDESK | 1056 | Q29RF7 | |
| RDAQSPDESKTNEKL | 1061 | Q29RF7 | |
| NPRESSKFIAENSRD | 6 | Q5T6V5 | |
| EEEDLPDAQTAAKRA | 161 | O43665 | |
| PASTNSDDVRDEKVK | 276 | P11413 | |
| NSLPDIEEVKDQSRN | 86 | P10914 | |
| SAAEPLDRSKFEENE | 946 | Q14573 | |
| SADDNLKTPSERQLT | 756 | F8W0I5 | |
| SIRQEPTNSQIDKSD | 896 | Q9Y5H9 | |
| KAKDDDDSDIPTAQR | 486 | O60271 | |
| RVDSLPASDDKDLNV | 281 | Q5SQ80 | |
| KRDNPEQFLEAAATS | 21 | D6REC4 | |
| DSSDSSPEKQERNLN | 251 | Q6ZW49 | |
| QEEAKPQVRDFSLTS | 196 | Q9NZ53 | |
| SLVKGNTPESNRDES | 2736 | Q14517 | |
| ENSNPEQDLKLTSEE | 371 | A5A3E0 | |
| ANPETQESEAKALLR | 146 | A6NCF5 | |
| RPVASDNDDEKQNSD | 216 | Q8WVC0 | |
| NPRRASKAVEESSDE | 131 | Q9BW71 | |
| QTDITDDSLDRKSPA | 1276 | P78559 | |
| STPAEDDSRDSQVKS | 336 | Q9UHB6 | |
| DDSRDSQVKSEVQQP | 341 | Q9UHB6 | |
| SKPQQDAEAASAEQR | 136 | Q96JK9 | |
| TASETESEKREEPNR | 451 | P51116 | |
| ESDDSVNTEDRILKP | 581 | Q8NI17 | |
| NNKDTAENRDSPVSE | 731 | Q7Z3F1 | |
| RTPDKLIDQVNDTSD | 1456 | O60303 | |
| TPSSEAKDSRLQDQR | 741 | Q99700 | |
| IKSITSNNDDEDLTP | 541 | P15884 | |
| NEQLLSRSVDSDEEP | 276 | Q9UNE0 | |
| QEDLPNDKRTSDTDE | 891 | Q8IYD8 | |
| KQNSESERRSPSSED | 351 | Q9BVA0 | |
| PEDKRKTASDSNLDR | 231 | Q8IWP9 | |
| ASPQRRNTASQEDKD | 206 | Q9Y6G9 | |
| ELESVSRDPSNENPK | 596 | O95786 | |
| ANSLSEKTRDPVEED | 691 | Q13191 | |
| SDPSAKILEESSQEQ | 6816 | Q5CZC0 | |
| LNKSPDFEEVTDRSQ | 86 | Q02556 | |
| AKETPSNEERLLDFN | 1321 | Q92628 | |
| QDSPLDLTVRKSQSE | 61 | Q96JN0 | |
| DLTVRKSQSEPSEQD | 66 | Q96JN0 | |
| EADQQEFDKSSTIPR | 536 | O43312 | |
| NNKSEDESAPKEVSR | 51 | Q9Y233 | |
| ETASSPKSQREINAD | 111 | Q8NHU0 | |
| IRISSAENKSAPDNE | 376 | Q1MSJ5 | |
| AAPKEDLTSDEEQRS | 856 | Q6ZNL6 | |
| KSDSDPQKSLEEREN | 606 | Q14005 | |
| KEESDSTERLQISNP | 356 | Q5TB30 | |
| SPETKNDRGNDLDTK | 1651 | P50851 | |
| AALRDEPSKVQTLNE | 561 | Q13136 | |
| QDALQDDPKETDNST | 146 | Q9H2C1 | |
| SADDNLKTPSERQLT | 506 | A8MRT5 | |
| SADDNLKTPSERQLT | 961 | A8MRT5 | |
| RIRSKSSPDENENEV | 151 | P32455 | |
| RIRSKSSPDENENED | 151 | Q9H0R5 | |
| TDTKDREPENNSLLE | 521 | P57789 | |
| SKKRPFEESETEQNN | 391 | Q9Y546 | |
| RIEFDNDADPTSESK | 96 | P23229 | |
| ELNSSAESEQPLDKT | 151 | Q9Y5B6 | |
| LSQPRRDSKGDSQED | 306 | Q13316 | |
| SADDNLKTPSERQLT | 506 | C9JG80 | |
| SADDNLKTPSERQLT | 966 | C9JG80 | |
| RDEFQTANSSDDKPL | 1901 | Q9C091 | |
| SQIRKLDEDASPNEE | 141 | Q9H0B6 | |
| SIRQEPTNSQIDKSD | 896 | Q9Y5I2 | |
| KRAVASQPDSVDAAE | 461 | Q9NVE7 | |
| SQPDSVDAAERAEKF | 466 | Q9NVE7 | |
| ENSNPEQDLKLTSEE | 371 | A0JP26 | |
| SADDNLKTPSERQLT | 426 | E5RHQ5 | |
| SADDNLKTPSERQLT | 976 | E5RHQ5 | |
| SIRQEPTNSQIDKSD | 911 | Q9H158 | |
| ENSNPEQELKLTSEE | 371 | Q6S8J3 | |
| LPDSSNKIEEDRCSN | 506 | Q52LW3 | |
| PSNNDLNTTEKRAAE | 241 | P38398 | |
| DLRNPEQSTSEKAVL | 1441 | P38398 | |
| NVPKQSSQLDEDRTE | 2586 | Q13315 | |
| RVDSLPASDDKDLNV | 281 | Q5VUR7 | |
| PSDVKELALDNSRSN | 16 | O43423 | |
| ADKVASLSREEPQDI | 26 | Q13042 | |
| ETASSPKSQREINAD | 111 | Q5HYN5 | |
| RSNKATTLPDAQDTE | 1981 | Q4AC94 | |
| RQEPSRFNIKEEASS | 116 | O14647 | |
| SDKDTDQRSSPDVAK | 171 | Q9NQL9 | |
| SDEDDPKRRAVQSQE | 711 | Q5JV73 | |
| QEENKERAEEQPSTS | 861 | Q5T1B0 | |
| EQSTPAEQKELGSER | 3471 | Q8N3K9 | |
| LKNAESDPRSSERDQ | 676 | Q6ZU35 | |
| EAERNNPLFEESKIS | 56 | C9J3I9 | |
| SEEQQESARAVPEKS | 811 | Q9BTC0 | |
| QNAEDLDDSDLPKTS | 1281 | Q9NSI6 | |
| SPREQDSESQTLDKV | 211 | Q14790 | |
| RIPAESDSSENSKEN | 541 | Q0VDD8 | |
| ADAESEPVAQKSQLD | 271 | O95243 | |
| LSPRQSKSDSDDDDL | 231 | Q9Y4X4 | |
| SRKPDAEEVSSDSEN | 771 | Q9ULL0 | |
| SEKRESQNPFRDDVS | 936 | Q9NRM1 | |
| ENSDDSRNKLSKIPS | 186 | Q9HC35 | |
| SPEDNVENVLKDSSR | 111 | Q9NVP4 | |
| SREAKNSDVLQSPLD | 601 | Q8NBJ5 | |
| SRARPQEKDDDQKDS | 496 | Q8IY37 | |
| EAQPARAENEKDATT | 1366 | P21817 | |
| NRTDDTSDPEKTVER | 3536 | Q92736 | |
| SSSASPQEQDQDRRK | 41 | O00411 | |
| SQKRDSQADDPENIK | 736 | O43432 | |
| ENSRPLQEKNTESSE | 506 | Q68DL7 | |
| ETASSPKSQREINAD | 111 | P0DMU7 | |
| DDSTLPLIDRNQKSD | 866 | O60716 | |
| NSSDDALNESKPDEV | 396 | Q8NG08 | |
| DPSDLQDTSNRVTVK | 101 | Q9UPQ0 | |
| SADDNLKTPSERQLT | 506 | A6NJU9 | |
| SADDNLKTPSERQLT | 756 | A6NJU9 | |
| SADDNLKTPSERQLT | 966 | A6NJU9 | |
| ESDSRKSSIPNNKEI | 1296 | P23468 | |
| ENSNPEQDLKLTSEE | 371 | B2RU33 | |
| EETSDRPENLITNKV | 141 | Q86XP0 | |
| ENDAFSDKSERENPE | 296 | Q9H0X9 | |
| RKEIDDAAQFATTDP | 341 | P29803 | |
| KQNPSTREAEEETTN | 286 | P43121 | |
| EPAKTDQAVSKDRNA | 326 | Q9NP80 | |
| ENSNPEQDLKLTSEE | 371 | Q86YR6 | |
| KALADPNQDEESVTD | 186 | Q6ZR62 | |
| KSVPAFLQDESDDRE | 561 | Q9HCH5 | |
| QEQTRQDAEKSDTSP | 156 | Q8TDW5 | |
| TPSEDEAKAETIRNL | 556 | O14994 | |
| ETVTRAEKSNPEESL | 141 | Q9H7C4 | |
| AEKSNPEESLRAEQS | 146 | Q9H7C4 | |
| VDDSVNNVRKDDPTL | 116 | P22061 | |
| SPQNDDALETRAKKS | 461 | O94972 | |
| EDSQKDLENDPSVNS | 11 | Q8NFQ8 | |
| KRALDSSPEANTEDD | 11 | B4DJY2 | |
| SDDETSPRDKQQKNS | 166 | Q96HN2 | |
| PSSAKRQQETAAAET | 171 | O15240 | |
| VKEESARNSPELASE | 311 | O95425 | |
| KTDVRTNINSSRDPD | 1551 | P12259 | |
| SAQEQREKQPLEESA | 66 | Q9HC36 | |
| LSDDNILEDRPENKS | 1596 | Q9P212 | |
| DSSEPQAKREKTELS | 686 | P48380 | |
| ERFENKLDPEASSIN | 626 | Q96RN1 | |
| ISSAVKSAPEENSRE | 331 | P32249 | |
| PEDTKSADSDRDVFN | 456 | Q96BP3 | |
| SADSDRDVFNEKPSK | 461 | Q96BP3 | |
| KREQISENPTEATDI | 746 | Q05209 | |
| PVFTRQDSNRSEKEA | 626 | Q9Y520 | |
| SENSNPEQDLKLTSE | 451 | P0CG39 | |
| PEQDLKLTSEEESQR | 456 | P0CG39 | |
| SDDSSRNLFVKDLPQ | 126 | Q5FBB7 | |
| TPFRQKVSNDSNREE | 346 | Q5FBB7 | |
| LSEDSPNSEQDLEKL | 1026 | Q5T5P2 | |
| QRDRNPSETQSKSES | 276 | Q9UIU6 | |
| ERETISAIDTSPKEN | 231 | Q6ZSJ9 | |
| ENSNPEQDLKLTSEE | 371 | P0CG38 | |
| IDNPAITSDQELDDK | 1211 | Q13017 | |
| SFSLEEDSDQASKPR | 2491 | Q9P2P6 | |
| SPKDAFETRQDLNEE | 156 | Q8NE31 | |
| RTASNPKVENEDEEL | 291 | Q9UBF8 | |
| TDQKQADSADKRPAE | 1721 | Q9H2D6 | |
| VASPAESDEENRQKT | 631 | Q01826 | |
| DSETERKDPQNALAE | 251 | O60284 | |
| NPSKAERENLALETS | 161 | E9PGG2 | |
| LDDFPDSRTNVDLKN | 121 | Q6IBW4 | |
| DSRTNVDLKNDQTPS | 126 | Q6IBW4 | |
| NETEADSKPSKNVAR | 956 | Q2KHT3 | |
| EEDGTRPQSTSDQKL | 391 | Q14028 | |
| DTNESEIKSNEEPLL | 21 | Q7LG56 | |
| RDDPSNKETASSLQA | 741 | Q92618 | |
| SSNREQRLEDKGDTP | 996 | O94966 | |
| VRTDSNNENSVPKDF | 146 | Q86Y38 | |
| NDQDSAIPRTTEKDK | 991 | A4D1E1 | |
| KRASVENVDADTPSA | 256 | P0CG00 | |
| VPNAESKSTQERERE | 1346 | Q8NI27 | |
| RLNESPTDDSEKEAS | 481 | Q70EL2 | |
| NDNADKTDRTTEPEQ | 351 | Q6GYQ0 | |
| PAKPNREDVSSSQEE | 1081 | Q9UJ98 | |
| SRLSPAFSQEEDKAE | 251 | Q9UBZ9 | |
| DRESKKADTNAPTDI | 606 | Q9UQP3 | |
| DSDIPSFLEDSNRAK | 936 | Q12767 | |
| SRETPLNQESARKSE | 26 | P35398 | |
| NIALDKTDDSNPREA | 591 | Q9NW82 | |
| RSEDLDNATEVNPKG | 346 | O95171 | |
| LERDDADSSIQFSKP | 271 | Q7Z699 | |
| EKPSVSQTSENRVDN | 521 | Q9BX26 | |
| LQDVIPDSQAAEKRD | 581 | Q9BX26 | |
| DDSRAIKTNQDLLPE | 26 | Q8N394 | |
| EPQKRASVENVDADT | 256 | A6NJL1 | |
| AQAEKVDRKASSNPD | 211 | Q8N0Z6 | |
| KQLPSSTSDDRVKDE | 341 | Q8N554 | |
| AQSDDEEKLQSQPTD | 401 | Q5JSH3 | |
| VESTDFANAPEESRK | 131 | P48594 | |
| ENSRCSPSTEDENKL | 206 | Q8WWQ8 | |
| ENKVADPVDSSNLDT | 86 | Q12888 | |
| EEAVDDSQLPKDRFS | 71 | A0A5A6 | |
| KQDSESNVDPRDDVF | 1606 | O00507 | |
| RKNETDSSLNQEAPT | 561 | Q8N841 | |
| SKLPEQEAAEADLSN | 176 | Q6UX27 | |
| DSTSKQRIFDEEPAN | 121 | Q9UJW8 | |
| RKNDILEEPVDSDST | 626 | Q9H582 | |
| ESVVDDSQLPKDRFS | 71 | A0A0K0K1C0 | |
| KDTRSSDDQKDDIPV | 191 | Q3SXZ7 | |
| LQPVEKREQAASEDA | 491 | Q96IT1 | |
| KRDTNAPESFKDTAE | 1896 | Q15643 | |
| SEAEKAENEDRTALP | 606 | P52739 | |
| PAQNASSEEVDRISK | 191 | Q86UQ0 | |
| KDLSAANRNDPVFET | 166 | Q96MF2 | |
| ARNDKSVKEIENSSP | 36 | Q5TAX3 | |
| LDDSSDSQDPTKEIR | 321 | Q14679 | |
| ENSNPEQDLKLTSEE | 371 | Q6S5H5 | |
| NPEQDLKLTSEEESQ | 411 | Q6S545 | |
| ENSNPEQDLKLTSEE | 371 | A6NI47 | |
| VVEAKTSEARPFNDS | 501 | Q92547 | |
| AVPADRKSNSTAAQE | 381 | O15231 | |
| SSPLDNKLNVEDVDS | 96 | Q8WXD2 | |
| VDTEPQKRNTEESSS | 96 | Q5T200 | |
| TDINADLASRDEPQK | 96 | Q8TAF7 | |
| NPSQKRDLDAITDIS | 321 | Q9Y2L8 | |
| SKGDPNTEEIRQSDE | 136 | P40222 | |
| DRASEPKSQDQDSEV | 71 | Q86VM9 | |
| PKSQDQDSEVNELSR | 76 | Q86VM9 | |
| SAESDTEQNPERKVE | 1806 | Q9P2D8 | |
| RESIDGKLPSTDQQE | 1241 | Q14789 | |
| DEESRFPKATDQTLV | 791 | Q8NEV4 |